Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review

.

Source: Expert Opinion on Biological Therapy - October 22, 2021 Category: Drugs & Pharmacology Authors: Mina Hosseini Zahra Habibi Narges Hosseini Sina Abdoli Nima Rezaei Source Type: research